The announcement comes as Moderna charts a path forward after the rapid decline in demand for its Covid vaccine ... allegedly inflating insulin prices Pfizer says drug for deadly cancer condition ...

“Mistakes that resulted in clinical data that was much more complex to interpret than Moderna’s and Pfizer’s. And on top of that the efficacy is lower.” Technology, price and storage. The AstraZeneca ...

It will compare the ... According to Pfizer and BioNTech, this is the first time that an mRNA-based flu vaccine has started a phase 3 efficacy trial. Its rival Moderna said earlier this month ...

View this interactive chart on Fortune.com You likely hadn’t heard of mRNA vaccines before the COVID-19 pandemic. Moderna and Fortune 500 competitor Pfizer’s messenger RNA COVID vaccines were ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, we found that the claim is false. According to an Instagram post ...

(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of ...

Should Big Pharma be worried? Analysts believe it bodes poorly for vaccine makers. But Pfizer (PFE) CEO Albert Bourla said he doesn't think so, in an interview with Yahoo Finance. In fact ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's nomination moved forward. © 2024 Fortune ...